These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
380 related items for PubMed ID: 31419209
21. Lack of correlation of ECV and outcome in an in vivo murine model of systemic fusariosis. Navarro-Rodríguez P, Guevara-Suarez M, Paredes K, Celis A, Guarro J, Capilla J. Diagn Microbiol Infect Dis; 2018 Oct; 92(2):124-126. PubMed ID: 30201117 [Abstract] [Full Text] [Related]
22. Disseminated amphotericin-resistant fusariosis in acute leukemia patients: report of two cases. Pereira GH, de Angelis DA, Brasil RA, dos Anjos Martins M, de Matos Castro e Silva D, Szeszs MW, de Souza Carvalho Melhem M. Mycopathologia; 2013 Feb; 175(1-2):107-14. PubMed ID: 23076561 [Abstract] [Full Text] [Related]
23. Disseminated fusariosis and hematologic malignancies, a still devastating association. Report of three new cases. García-Ruiz JC, Olazábal I, Adán Pedroso RM, López-Soria L, Velasco-Benito V, Sánchez-Aparicio JA, Navajas A, Montejo M, Moragues MD. Rev Iberoam Micol; 2015 Feb; 32(3):190-6. PubMed ID: 25936697 [Abstract] [Full Text] [Related]
24. Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review. Fanci R, Pini G, Bartolesi AM, Pecile P. Rev Iberoam Micol; 2013 Jan 03; 30(1):51-3. PubMed ID: 22659590 [Abstract] [Full Text] [Related]
25. [Detection of virulence factors and antifungal susceptibilities of Fusarium strains isolated from keratitis cases]. Çuhadar T, Karabıçak N, Özdil T, Özgür D, Otağ F, Hızel K, Kalkancı A. Mikrobiyol Bul; 2018 Jul 03; 52(3):247-258. PubMed ID: 30156511 [Abstract] [Full Text] [Related]
26. Infections Caused by Fusarium Species in Pediatric Cancer Patients and Review of Published Literature. Arnoni MV, Paula CR, Auler ME, Simões CCN, Nakano S, Szeszs MW, Melhem MSC, Pereira VBR, Garces HG, Bagagli E, Silva EG, de Macêdo MF, Ruiz LDS. Mycopathologia; 2018 Dec 03; 183(6):941-949. PubMed ID: 29564632 [Abstract] [Full Text] [Related]
27. [Fusariosis diagnosed in the laboratory of an UH in Tunisia: epidemiological, clinical and mycological study]. Néji S, Trabelsi H, Cheikhrouhou F, Sellami H, Guidara R, Trigui A, Feki J, Boudaya S, Turki H, Makni F, Ayadi A. J Mycol Med; 2013 Jun 03; 23(2):130-5. PubMed ID: 23725904 [Abstract] [Full Text] [Related]
28. Molecular analyses of Fusarium isolates recovered from a cluster of invasive mold infections in a Brazilian hospital. Scheel CM, Hurst SF, Barreiros G, Akiti T, Nucci M, Balajee SA. BMC Infect Dis; 2013 Jan 30; 13():49. PubMed ID: 23363475 [Abstract] [Full Text] [Related]
29. In vitro antifungal susceptibility of clinical isolates of Fusarium from Colombia. Gaviria-Rivera A, Giraldo-López A, Cano-Restrepo LE. Rev Salud Publica (Bogota); 2017 Jan 30; 19(6):800-805. PubMed ID: 30183834 [Abstract] [Full Text] [Related]
30. Fusarium Keratitis in Germany. Walther G, Stasch S, Kaerger K, Hamprecht A, Roth M, Cornely OA, Geerling G, Mackenzie CR, Kurzai O, von Lilienfeld-Toal M. J Clin Microbiol; 2017 Oct 30; 55(10):2983-2995. PubMed ID: 28747368 [Abstract] [Full Text] [Related]
31. Overinduction of CYP51A Gene After Exposure to Azole Antifungals Provides a First Clue to Resistance Mechanism in Fusarium solani Species Complex. D'Agostino M, Lemmet T, Dufay C, Luc A, Frippiat JP, Machouart M, Debourgogne A. Microb Drug Resist; 2018 Oct 30; 24(6):768-773. PubMed ID: 29676953 [Abstract] [Full Text] [Related]
32. Mycotic Keratitis Caused by Fusarium solani sensu stricto (FSSC5): A Case Series. Boral H, van Diepeningen A, Erdem E, Yağmur M, de Hoog GS, Ilkit M, Meis JF, Al-Hatmi AMS. Mycopathologia; 2018 Oct 30; 183(5):835-840. PubMed ID: 29931660 [Abstract] [Full Text] [Related]
33. [Molecular identification and in vitro susceptibility of Fusarium from fungal keratitis in central China]. Sun S, Lyu Q, Han L, Ma Q, Hu H, He S, Tao S, Zhang J, Zhang H, Wang L. Zhonghua Yan Ke Za Zhi; 2015 Sep 30; 51(9):660-7. PubMed ID: 26693650 [Abstract] [Full Text] [Related]
34. Current antifungal treatment of fusariosis. Al-Hatmi AMS, Bonifaz A, Ranque S, Sybren de Hoog G, Verweij PE, Meis JF. Int J Antimicrob Agents; 2018 Mar 30; 51(3):326-332. PubMed ID: 28705676 [Abstract] [Full Text] [Related]
35. Molecular Characterization and Antifungal Susceptibility of Clinical Fusarium Species From Brazil. Herkert PF, Al-Hatmi AMS, de Oliveira Salvador GL, Muro MD, Pinheiro RL, Nucci M, Queiroz-Telles F, de Hoog GS, Meis JF. Front Microbiol; 2019 Mar 30; 10():737. PubMed ID: 31024507 [Abstract] [Full Text] [Related]
36. In vitro interactions of antifungal agents against clinical isolates of Fusarium spp. Córdoba S, Rodero L, Vivot W, Abrantes R, Davel G, Vitale RG. Int J Antimicrob Agents; 2008 Feb 30; 31(2):171-4. PubMed ID: 18054469 [Abstract] [Full Text] [Related]
38. Luliconazole, a highly effective imidazole, against Fusarium species complexes. Gharaghani M, Hivary S, Taghipour S, Zarei-Mahmoudabadi A. Med Microbiol Immunol; 2020 Oct 30; 209(5):603-612. PubMed ID: 32253502 [Abstract] [Full Text] [Related]
39. Epidemiological Study of Fusarium Species Causing Invasive and Superficial Fusariosis in Japan. Muraosa Y, Oguchi M, Yahiro M, Watanabe A, Yaguchi T, Kamei K. Med Mycol J; 2017 Oct 30; 58(1):E5-E13. PubMed ID: 28250364 [Abstract] [Full Text] [Related]
40. Fusariosis in a Patient with Acute Myeloid Leukemia: A Case Report and Review of the Literature. Delia M, Monno R, Giannelli G, Ianora AA, Dalfino L, Pastore D, Capolongo C, Calia C, Tortorano A, Specchia G. Mycopathologia; 2016 Jun 30; 181(5-6):457-63. PubMed ID: 27008433 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]